Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination

Clinical trial NCT04470310 · UNKNOWN

Trial details

NCT number: NCT04470310
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2015-12-31
Primary completion: 2019-05-20
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.